Arbutus Biopharma CEO to retire as company cuts workforce by 24%

The layoffs at Arbutus are tied to the company's decision in September to narrow its research focus in order to conserve cash.

Previous H.I.G. Capital portfolio company acquires Mexican chemical distributor
Next Another Kentucky neighbor votes in favor of legalizing recreational marijuana